Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,405.66 +470.90 (+1.24%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
60,033.88 -2,929.20 (-4.65%) CMC Crypto 200
1,279.01 -60.05 (-4.48%)
BioNexus Gene Lab Corp. (BGLC)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 10.60M |
| Enterprise value | 4.80M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.97 |
| Price/book (mrq) | 1.10 |
| Enterprise value/revenue | 0.49 |
| Enterprise value/EBITDA | -1.93 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.95 |
| 52-week change 3 | 82.93% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 9.4900 |
| 52-week low 3 | 0.0800 |
| 50-day moving average 3 | 0.7048 |
| 200-day moving average 3 | 0.8795 |
Share statistics
| Avg vol (3-month) 3 | 1.58M |
| Avg vol (10-day) 3 | 467.88k |
| Shares outstanding 5 | 17.67M |
| Implied shares outstanding 6 | 17.67M |
| Float 8 | 9.96M |
| % held by insiders 1 | 64.38% |
| % held by institutions 1 | 0.59% |
| Shares short (15 Apr 2024) 4 | 99.74k |
| Short ratio (15 Apr 2024) 4 | 1.15 |
| Short % of float (15 Apr 2024) 4 | 0.58% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.56% |
| Shares short (prior month 15 Mar 2024) 4 | 20.06k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -26.91% |
| Operating margin (ttm) | 7.36% |
Management effectiveness
| Return on assets (ttm) | -12.68% |
| Return on equity (ttm) | -32.21% |
Income statement
| Revenue (ttm) | 9.77M |
| Revenue per share (ttm) | 0.62 |
| Quarterly revenue growth (yoy) | -20.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -1.96M |
| Net income avi to common (ttm) | -2.63M |
| Diluted EPS (ttm) | -0.1800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 5.93M |
| Total cash per share (mrq) | 0.34 |
| Total debt (mrq) | 146.59k |
| Total debt/equity (mrq) | 1.52% |
| Current ratio (mrq) | 4.93 |
| Book value per share (mrq) | 0.55 |
Cash flow statement
| Operating cash flow (ttm) | -1.3M |
| Levered free cash flow (ttm) | 566.75k |
© 2024 Yahoo. All rights reserved.